RAD 2.86% 3.6¢ radiopharm theranostics limited

Ann: Entitlement Offer Documents, page-10

  1. 1,247 Posts.
    lightbulb Created with Sketch. 185
    Dude, of the 100+ ASX biotechs, only TLX, CUV, PNV, NAN, CYC and maybe MVP would come close to 'going concern'.

    The vast majority (like RAD) live hand to mouth on multiple dilutive downrounds untill they either; a) hit the jackpot or b) run out of runway. Thats the lottery of biotech. Going concern is simply...of no concern to investors.
 
watchlist Created with Sketch. Add RAD (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.